171 related articles for article (PubMed ID: 6644338)
1. Second counterpoint: animal tumor models and their relevance to human tumor immunology.
Herberman RB
J Biol Response Mod; 1983; 2(3):217-26. PubMed ID: 6644338
[No Abstract] [Full Text] [Related]
2. Counterpoint: animal tumor models and their relevance to human tumor immunology.
Herberman RB
J Biol Response Mod; 1983; 2(1):39-46. PubMed ID: 6644330
[No Abstract] [Full Text] [Related]
3. Second point: animal tumor models and their relevance to human tumor immunology.
Hewitt HB
J Biol Response Mod; 1983; 2(3):210-6. PubMed ID: 6644337
[TBL] [Abstract][Full Text] [Related]
4. Appropriateness of animal models for the immunology of human cancer.
Rapp HJ
Cancer Res; 1979 Oct; 39(10):4285-7. PubMed ID: 476659
[No Abstract] [Full Text] [Related]
5. Why does a tumor grow.
Ablin RJ
Allergol Immunopathol (Madr); 1976; 4(6):449-60. PubMed ID: 1016534
[No Abstract] [Full Text] [Related]
6. Tumor immunology.
Transplant Proc; 1975 Mar; 7(1 Suppl 1):473-555. PubMed ID: 1053512
[No Abstract] [Full Text] [Related]
7. Tumor immunology--three decades in review.
Brodt P
Annu Rev Microbiol; 1983; 37():447-76. PubMed ID: 6227278
[No Abstract] [Full Text] [Related]
8. Immunity to malignant disease in man.
Fairley GH
Sci Basis Med Annu Rev; 1971; ():17-38. PubMed ID: 4933915
[No Abstract] [Full Text] [Related]
9. Immunity in malignant disease.
Fairley GH
Trans Med Soc Lond; 1968; 84():96-109. PubMed ID: 5708160
[No Abstract] [Full Text] [Related]
10. Cancer and immunology.
Curr Opin Immunol; 1989 Jun; 1(5):971-1051. PubMed ID: 2679747
[No Abstract] [Full Text] [Related]
11. Neuraminidase induced immunospecific destruction of transplantable experimental tumors.
Sethi KK; Teschner M
Postepy Hig Med Dosw; 1974; 28(1):103-20. PubMed ID: 4816378
[No Abstract] [Full Text] [Related]
12. The nature of the immunological interaction between the host and the tumor.
Alexander P
Laryngoscope; 1975 Mar; 85(3):487-90. PubMed ID: 1121223
[No Abstract] [Full Text] [Related]
13. Transplantation of human cancers to hamster cheek pouches.
Patterson WB
Cancer Res; 1968 Aug; 28(8):1637-51. PubMed ID: 5676964
[No Abstract] [Full Text] [Related]
14. Tumor immunology.
Shehadeh IH
J Med Liban; 1972; 25(3):199-203. PubMed ID: 5086706
[No Abstract] [Full Text] [Related]
15. The present status of immunodiagnosis and immunotherapy of cancer.
Pasternak G
Arch Geschwulstforsch; 1981; 51(4):284-93. PubMed ID: 7032448
[TBL] [Abstract][Full Text] [Related]
16. [Immunological properties of tumor cells that determine the degree of their malignancy].
Lavrovskiĭ VA; Viksler VKh
Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110
[No Abstract] [Full Text] [Related]
17. Current aspects of immunotherapy in cancer.
Langenbecks Arch Chir; 1981; 354(1):1-17. PubMed ID: 7253782
[No Abstract] [Full Text] [Related]
18. Recent trends in tumor immunology.
Klein G
Isr J Med Sci; 1966; 2(2):135-42. PubMed ID: 5330329
[No Abstract] [Full Text] [Related]
19. [Aspects of immunotherapy in malignant tumors].
Gericke D
Med Klin; 1968 Jul; 63(29):1143-6. PubMed ID: 4976478
[No Abstract] [Full Text] [Related]
20. [Cancer immunology].
Sjögren HO
Lakartidningen; 1966 Mar; 63(13):1247-56. PubMed ID: 5919985
[No Abstract] [Full Text] [Related]
[Next] [New Search]
